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attacking action of the immune cells with an armamentarium of drugs that includes aspirin-like substances, corticosteroids, and other so-called disease-modifying anti-rheumatic drugs. While such drugs can be effective, toxicity significantly limits their use in some cases, and treatment failure limits them in others. Another mainstay of therapy is drugs that target cytokines, molecules produced by white blood cells during inflammation. In a healthy immune response, cytokines ward off infection and promote tissue repair, but when the body produces these same molecules in excess, they are highly toxic. In rheumatoid arthritis, high cytokine levels accumulate in the cartilage and other inflamed joint tissues to produce pain and destroy tissues.
Treatments that specifically block the action of cytokines have shown major promise in alleviating the disease in some autoimmune patients. These advanced drugs have now been administered to millions of individuals, providing insight into the important role that cytokines play in the development of the disease. The downside, however, is that these drugs are powerful immune system-suppressing agents that impair defenses, which can leave the patient susceptible to major infection. Some of these therapies even carry a black box warning, a notice mandated by the FDA that immunosuppressive side effects can be extremely dangerous, or even fatal.
Furthermore, the widespread adoption of these agents is hampered by cost, which may run as high as $30,000 per patient annually. Even if patients undertake these risks and costs, 50 percent fail to achieve significant clinical benefit. So there obviously remains a major unmet medical need for the development of new treatment options for rheumatoid arthritis and other autoimmune diseases.
Healthy Nervous System Regulation
The origin of the device being tested in Bosnia came from studying body mechanisms that evolved to regulate one of the major toxic cytokines, termed TNF. The first cytokine that researchers successfully targeted to provide clinical benefit in rheumatoid arthritis patients (others have followed), TNF occupies a crucial role in triggering painful destruction of the joints. 2 In healthy people, the nervous system provides a precise mechanism of checks and balances that maintains the levels of TNF within a safe range. But in rheumatoid arthritis, like brake failure in a car barreling down a mountain, the neural control exerted by the vagus nerve fails and the production of TNF goes out of control. Very recent insights have revealed that it Cerebrum, March 2012 4 may be possible to restore the vagus nerve signals that are missing in these patients and reestablish safe levels of TNF. 3 That the vagus nerve controls TNF production is quite consistent with long-known principles about how the body works: health is possible because the body regulates organ function within a narrow, optimal range. For example, body temperature is maintained at 37
degrees Celsius, and normal heart rate is 72 beats per minute. Healthy physiological systems adjust organ function around an ideal set point through a process called homeostasis, and the nervous system plays a critical role in regulating the activity of body organs within this healthy range.
It does so through a network of involuntary, or autonomic, nerves, which, as the name implies, act without conscious input. These neurons project to all of the body's major organs, including heart, lungs, kidneys, spleen, and digestive tract. We don't have to think about digesting our food or accelerating our heart rate during exercise because these processes are regulated by the involuntary nervous system. The basic mechanism underlying homeostasis is set in motion when sensory nerves send minute-to-minute information about the status of the organs back to the brain. The brain processes the incoming data in neural feedback loops, resulting in return instructions being sent back to the organs to maintain function within a healthy range.
Neurons in these networks communicate with other cells by transmitting information as small electrical spikes, called action potentials. These propagate very quickly along nerve axons to stimulate the release of neurotransmitters from the nerve ending. The release of these molecules converts the electrical signal into a chemical one; the neurotransmitters travel a short distance away from the nerve ending and then bind to receptors on adjacent cells, acting like drugs to change the behavior of the cell. The receiving cell can be another neuron, a muscle cell, or a white blood cell, and binding of the neurotransmitter to the specific receptor signals the receiving cell to modify its metabolism, biochemical activity, and gene-expression patterns.
The fundamental guiding principles by which autonomic neural circuits regulate organ function have been known for decades. For example, to regulate heart rate, sensory nerve fibers detect the resting heart rate and relay that information to the brain stem, which in turn sends instructions via nerves traveling from the brain stem to the heart, causing heart rate to either slow or accelerate. The net effect of this closed-loop circuit is like the thermostat on the wall of your home, in which deviation from a set point activates a signal to compensate for the change.
Autonomic nerve reflex circuits operate continuously to and from the principal organs, below the level of normal consciousness. Despite this advanced knowledge, only quite recently did studies surprisingly reveal that similar principles apply to the immune system.
In this nervous-system-to-immune-system circuit, sensory nerves detect the presence of molecules produced during inflammation, initiating a report to the brain. This is the first step in a reflexive circuit that maintains immunological homeostasis (See Figure 1) . The resultant outbound neural signals to the immune system are carried in the vagus nerve to slow down the inflammatory response. Some of these signals travel to the spleen, a spongy blood-filled organ adjacent to the stomach, where immune cells are a major source of TNF in the body. Thus, cytokine-blocking signals originating in the brain stem travel down the vagus nerve until they reach the abdomen, where they terminate upon neurons that in turn travel in the splenic nerve,
Figure 1
The neural circuitry underlying the inflammatory reflex. Pathogens and other molecules produced during tissue damage stimulate macrophages and other immune cells to produce cytokines. These activate sensory neurons, which send information via the afferent arc of the reflex to the brain. In the brain stem these signals are processed, then relayed to the outgoing neurons in the efferent arc, which travel back to the immune system in the spleen and other organs to suppress cytokine release. The complete inflammatory reflex provides a brake that suppresses the production of cytokines. 
